Medtech Insight and Windhover Information's 2006 ``Investment in Innovation (In3) Europe: A Preview of Emerging Medical Technologies``; Israel as Device Hotbed is Subject of Dynamic Panel Discussion.

NORWALK, Conn. -- September 18-20, 2006, Crowne Plaza, Brussels City Centre, Belgium

New presenting companies from around the world, along with stimulating keynote sessions, are being added daily to the agenda of the 2006 "Investment in Innovation (In3) Europe: A Preview of Emerging Technologies" conference, slated for Sept. 18-20 in Brussels.

With the landmark event only weeks away, spaces are filling quickly, but registrations are still being accepted at http://www.medtechinsight.com/in3-europe-02.html.

In3 Europe, sponsored by Medtech Insight, a division of Windhover Information, is the industry's most efficient strategic partnering and investment meeting for the international medtech development community. The audience will be comprised of hundreds of senior-level decision-makers from most of the major medtech companies and healthcare investment firms worldwide, representing most of the major dealmakers in the medical technology industry.

Dynamic agenda planned for conference

In addition to its premier opportunities for networking and partnering throughout the event, In3 Europe will feature a number of eminent healthcare executives as speakers and an in-depth industry panel discussion.

New sessions just announced include a groundbreaking discussion entitled "What Makes Israel Such a Dynamic Device Company Developer?" This session will feature a panel of leading venture capitalists and serial entrepreneurs, moderated by David Cassak, Managing Partner of Windhover Information.

Panelists will Zeev Zehavi, Vice President, Johnson & Johnson Development Corporation; Yuval Binur, Ph.D., Chairman of the Board, Accelerated Technologies; Nissim Darvish, M.D., DSc., Partner, Pitango Venture Capital; and Avi Molcho, M.D., Managing Director, Life Sciences, Giza Venture Capital.

Also announced is "The Seven Drivers of Value: Optimize Your VC Funding and Exit" a panel discussion to be moderated by Christopher J.P. Velis, Chairman & CEO, Medical Capital Advisors. Panelists for this session will be announced shortly.

The agenda also includes:

--"Best Practices for Venture Investing in Europe" with Michel Lussier, CEO of MedPole, Chairman of Cardio3 and VP & General Manager of European Operations for Volcano

--"Medtech Investing in Europe: the 3i Perspective" with Andrew Fraser Partner, 3i

--"The European Route: First CE-mark and then FDA approval; does it make sense?" with Dirk Meijer, M.D., Ph.D., CEO, Factory CRO

--Late-Stage Dealmaking: Venture Capital Perspectives

--Exit Strategy Case Studies Panel: Getting Sold vs. Going Public

--Venture Capital Investing in Medical Technology Companies - 2006 State of Affairs

For a complete agenda, visit http://www.medtechinsight.com/Agenda-in3-europe-02.html.

More than 50 companies to present

Emerging medical technology companies from around the world seeking funding, acquisition and/or strategic partnership opportunities are scheduled to present at the conference. The newest presenters added to the list are:

Althera Medical, Tel Aviv, Israel
    DART is utilizing an interstitial radiation source that by nuclear
    decay recoil mechanism emits high-energy alpha particles widely
    dispersed by diffusion and by convection in the tumor mass.

    Harvest Technologies Corp., Plymouth, MA
    (technology description available soon)

    Lapeyre Industries, Eysines, France
    trileaflet mechanical heart valve designed to eradicate structural
    failure and the need of lifelong anticoagulation therapy

    MINVASYS, Gennevilliers, France
    dedicated angioplasty and stent systems for the treatment of
    arterial bifurcations

    Ranier Technology, Cambridge, United Kingdom
    compliant artificial lumbar disc with graduated modulus for
    restoration of normal spine biomechanics and enhanced durability

The complete list of presenters to date is available at http://www.medtechinsight.com/in3-europe-02.html#presenters.

The forum will provide focused overviews by a senior executive from each presenting company, followed by the opportunity to meet one-on-one in private breakout rooms, along with one-on-one meetings with company representatives in private breakout rooms and table-top exhibits and product prototypes by presenting companies during a networking dinner.

Huge array of global companies signed up to attend

Companies registered to attend to date include 3i, 3i Group PLC, Abbott Laboratories, ABMI SA, AION Diagnostics Ltd., Arbel Medical Ltd., Arrow International Inc., Aubrey Group Inc., Battelle - Health and Life Sciences, Baxter R&D Europe, BioImagene Inc., Biosan Medical Ltd., Blue Corporate Finance GmbH & Co KG, BOC Group (MEdical), Boston Scientific International SA, C.R. Bard Inc., Card Guard Scientific Survival Ltd., Cardinal Health, Cardio3 SA, Cheetah Medical Inc., Datascope, Delta Partners, Diagnostic Devices Inc. (DDI), Dialog Devices Ltd., DSM New Business Development, Earlybird Ventures, EBD Group, Factory CRO, Factory CRO for Clinical Research, Ferrosan A/S, Giza Venture Capital, Global Orthopaedic Technology Pty Ltd, HealthLink Europe, IIC GmbH, Imperial College London, Inion Oy, Innovate UK, InspireMD, Investor Growth Capital Inc., Itochu International Inc., Johnson & Johnson Development Corp., Kobayashi Medical, Krauth Medical, KG (GmbH & Co.), Kyphon Europe BVBA, Lapeyre Industries, Matignon Technologies FCPR, Medica Venture Partners, Medical Capital Advisors, Medical Capital Advisors LLC, Medtronic Inc., mNemoscience GmbH, Morgan Stanley, Morris Innovative Research, Naiot Technological Center Ltd., Novashunt Inc., OZ Recovery Technologies Ltd., Pitango Venture Capital, PreSRV Ltd., Protomed SARL, Provista Life Sciences LLC, Ronald Trahan Associates Inc., Sorin S.p.A., SPEF Venture, Stentys, Stryker Orthopaedics, SutureAid Inc., Synectic Engineering Inc., Synovis Life Technologies, Tibion Corporation, Triage Medical Inc., Tyco Healthcare, Victhom Human Bionics Inc., and WideMed Ltd.

Co-sponsors for In3 Europe include 3i, Battelle, Business Wire, Factory, Medical Capital Advisers, Ronald Trahan Associates and T for G.

Registrations now being accepted

Medtech Insight's conferences have drawn over 6,100 attendees and 700 innovative early-stage presenting companies over the past five years. Participating companies send multiple attendees, including company presidents, CEOs, partners, and VPs for business development, marketing, acquisitions, corporate development and R&D.

To register, call Kristy Grimes of Medtech Insight at 480-985-9512, or 888-202-5939 toll-free in the U.S.; e-mail [e-mail]; or register on the In3 Europe website at http://www.medtechinsight.com/in3-europe-02.html.

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.